{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:31:47Z","timestamp":1790285507743,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31370930"],"award-info":[{"award-number":["31370930"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["13431900601"],"award-info":[{"award-number":["13431900601"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["13ZR1462900"],"award-info":[{"award-number":["13ZR1462900"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["KSCX2-YW-BR-2"],"award-info":[{"award-number":["KSCX2-YW-BR-2"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["KSCX2-EW-R-17-1"],"award-info":[{"award-number":["KSCX2-EW-R-17-1"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Pasteur Foundation"},{"DOI":"10.13039\/501100002843","name":"Shanghai Institutes for Biological Science (SIBS), Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.vaccine.2014.06.025","type":"journal-article","created":{"date-parts":[[2014,6,17]],"date-time":"2014-06-17T13:31:05Z","timestamp":1403011865000},"page":"4296-4303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice"],"prefix":"10.1016","volume":"32","author":[{"given":"Zhiqiang","family":"Ku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yicun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dapeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.vaccine.2014.06.025_bib0005","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1017\/S0950268809991555","article-title":"Human enterovirus 71 and hand, foot and mouth disease","volume":"138","author":"Wong","year":"2010","journal-title":"Epidemiol Infect"},{"issue":"12","key":"10.1016\/j.vaccine.2014.06.025_bib0010","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/00006454-199912000-00013","article-title":"Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998","volume":"18","author":"Chang","year":"1999","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2014.06.025_bib0015","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1128\/JCM.00718-06","article-title":"Genetic diversity of coxsackievirus A16 associated with hand, foot, and mouth disease epidemics in Japan from 1983 to 2003","volume":"45","author":"Hosoya","year":"2007","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2014.06.025_bib0020","doi-asserted-by":"crossref","first-page":"254","DOI":"10.7883\/yoken.JJID.2009.254","article-title":"Genetic changes of coxsackievirus A16 and enterovirus 71 isolated from hand, foot, and mouth disease patients in Toyama, Japan between 1981 and 2007","volume":"62","author":"Iwai","year":"2009","journal-title":"Jpn J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2014.06.025_bib0025","doi-asserted-by":"crossref","first-page":"106","DOI":"10.47102\/annals-acadmedsg.V38N2p106","article-title":"Epidemiology and control of hand, foot and mouth disease in Singapore, 2001\u20132007","volume":"38","author":"Ang","year":"2009","journal-title":"Ann Acad Med Singapore"},{"issue":"1","key":"10.1016\/j.vaccine.2014.06.025_bib0030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1574-6976.2002.tb00601.x","article-title":"An overview of the evolution of enterovirus 71 and its clinical and public health significance","volume":"26","author":"McMinn","year":"2002","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2014.06.025_bib0035","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/1743-422X-8-534","article-title":"Construction and characterization of an infectious clone of coxsackievirus A16","volume":"8","author":"Liu","year":"2011","journal-title":"Virol J"},{"issue":"11","key":"10.1016\/j.vaccine.2014.06.025_bib0040","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S1473-3099(10)70194-8","article-title":"Virology, epidemiology, pathogenesis, and control of enterovirus 71","volume":"10","author":"Solomon","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2014.06.025_bib0045","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/INF.0b013e3181a41d63","article-title":"Diseases caused by enterovirus 71 infection","volume":"28","author":"Lee","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"20","key":"10.1016\/j.vaccine.2014.06.025_bib0050","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1016\/j.vaccine.2010.03.003","article-title":"EV71: an emerging infectious disease vaccine target in the Far East?","volume":"28","author":"Xu","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2014.06.025_bib0055","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1586\/erv.09.152","article-title":"Development of enterovirus 71 vaccines","volume":"9","author":"Lee","year":"2010","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2014.06.025_bib0060","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11684-012-0237-z","article-title":"Progress on the research and development of human enterovirus 71 (EV71) vaccines","volume":"7","author":"Liang","year":"2013","journal-title":"Front Med"},{"issue":"4","key":"10.1016\/j.vaccine.2014.06.025_bib0065","first-page":"339","article-title":"[Analysis on the epidemiological and genetic characteristics of enterovirus type 71 and Coxsackie A16 virus infection in Jiangsu, China]","volume":"30","author":"Pan","year":"2009","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"5","key":"10.1016\/j.vaccine.2014.06.025_bib0070","first-page":"334","article-title":"[To investigate pathogen of hand, foot and mouth disease in Shenzhen in 2008]","volume":"23","author":"Zhang","year":"2009","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi"},{"key":"10.1016\/j.vaccine.2014.06.025_bib0075","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJM196305092681904","article-title":"Fatal infection in an infant associated with Coxsackie virus group A, type 16","volume":"268","author":"Wright","year":"1963","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2014.06.025_bib0080","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S0022-3476(63)80047-5","article-title":"Myocarditis possibly due to Coxsackie group A, type 16, virus","volume":"62","author":"Goldberg","year":"1963","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.vaccine.2014.06.025_bib0085","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/01.inf.0000115950.63906.78","article-title":"Fatal coxsackievirus A16 infection","volume":"23","author":"Wang","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"10.1016\/j.vaccine.2014.06.025_bib0090","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3201\/eid1307.070295","article-title":"Fatal coxsackievirus A-16 pneumonitis in adult","volume":"13","author":"Legay","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2014.06.025_bib0095","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.3201\/eid1510.090594","article-title":"Rhombencephalitis and coxsackievirus A16","volume":"15","author":"Goto","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2014.06.025_bib0100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1743-422X-9-8","article-title":"Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications","volume":"9","author":"Xu","year":"2012","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2014.06.025_bib0105","first-page":"3341","article-title":"Severe hand-foot-and-mouth disease caused by mixed infection of enterovirus 71 and coxsackie A16: reports of 6 cases","volume":"29","author":"Zhang","year":"2011","journal-title":"Chin Gen Pract"},{"issue":"9882","key":"10.1016\/j.vaccine.2014.06.025_bib0110","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(13)61049-1","article-title":"Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"381","author":"Zhu","year":"2013","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.vaccine.2014.06.025_bib0115","doi-asserted-by":"crossref","first-page":"e1737","DOI":"10.1371\/journal.pntd.0001737","article-title":"Challenges to licensure of enterovirus 71 vaccines","volume":"6","author":"Lee","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"22","key":"10.1016\/j.vaccine.2014.06.025_bib0120","doi-asserted-by":"crossref","first-page":"11967","DOI":"10.1128\/JVI.00902-12","article-title":"A neonatal mouse model of coxsackievirus A16 for vaccine evaluation","volume":"86","author":"Mao","year":"2012","journal-title":"J Virol"},{"issue":"47","key":"10.1016\/j.vaccine.2014.06.025_bib0125","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1016\/j.vaccine.2012.08.071","article-title":"A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge","volume":"30","author":"Liu","year":"2012","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.vaccine.2014.06.025_bib0130","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.vaccine.2013.03.007","article-title":"Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection","volume":"31","author":"Cai","year":"2013","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.vaccine.2014.06.025_bib0135","doi-asserted-by":"crossref","first-page":"10445","DOI":"10.1007\/s00253-013-5257-3","article-title":"Virus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against Coxsackievirus A16 in mice","volume":"97","author":"Zhao","year":"2013","journal-title":"Appl Microbiol Biotechnol"},{"issue":"21","key":"10.1016\/j.vaccine.2014.06.025_bib0140","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.vaccine.2014.03.012","article-title":"A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses","volume":"32","author":"Cai","year":"2014","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2014.06.025_bib0145","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0966-842X(03)00208-7","article-title":"Virus-like particles as immunogens","volume":"11","author":"Noad","year":"2003","journal-title":"Trends Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2014.06.025_bib0150","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1586\/14760584.6.3.381","article-title":"Virus-like particles: flexible platforms for vaccine development","volume":"6","author":"Chackerian","year":"2007","journal-title":"Expert Rev Vaccines"},{"issue":"15","key":"10.1016\/j.vaccine.2014.06.025_bib0155","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.vaccine.2008.01.058","article-title":"Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge","volume":"26","author":"Chung","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2014.06.025_bib0160","doi-asserted-by":"crossref","first-page":"e57601","DOI":"10.1371\/journal.pone.0057601","article-title":"Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps","volume":"8","author":"Ku","year":"2013","journal-title":"PLoS One"},{"issue":"32","key":"10.1016\/j.vaccine.2014.06.025_bib0165","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1016\/j.vaccine.2013.05.019","article-title":"Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice","volume":"31","author":"Li","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2014.06.025_bib0170","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jviromet.2011.01.016","article-title":"Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins","volume":"173","author":"Liu","year":"2011","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2014.06.025_bib0175","first-page":"493","article-title":"A simple method of estimating 50 percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hyg"},{"issue":"1","key":"10.1016\/j.vaccine.2014.06.025_bib0180","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jviromet.2012.09.024","article-title":"Characterization of enterovirus 71 capsids using subunit protein-specific polyclonal antibodies","volume":"187","author":"Liu","year":"2013","journal-title":"J Virol Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2014.06.025_bib0185","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.virusres.2006.12.005","article-title":"Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides","volume":"125","author":"Foo","year":"2007","journal-title":"Virus Res"},{"issue":"17","key":"10.1016\/j.vaccine.2014.06.025_bib0190","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.vaccine.2013.02.051","article-title":"Identification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16","volume":"31","author":"Shi","year":"2013","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2014.06.025_bib0195","first-page":"535","article-title":"[Expression of VP0 protein of enterovirus 71 in Escherichia coli and generation of the corresponding polyclonal antibodies in guinea pigs]","volume":"27","author":"Feng","year":"2011","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"issue":"1-2","key":"10.1016\/j.vaccine.2014.06.025_bib0200","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jviromet.2012.06.025","article-title":"Development of murine monoclonal antibodies with potent neutralization effects on enterovirus 71","volume":"186","author":"Ku","year":"2012","journal-title":"J Virol Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2014.06.025_bib0205","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1128\/JVI.01848-13","article-title":"Chimeric virus-like particle vaccines displaying conserved enterovirus 71 epitopes elicit protective neutralizing antibodies in mice through divergent mechanisms","volume":"88","author":"Ye","year":"2014","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2014.06.025_bib0210","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1177\/1535370212473703","article-title":"Challenges for the formulation of a universal vaccine against dengue","volume":"238","author":"Chokephaibulkit","year":"2013","journal-title":"Exp Biol Med (Maywood)"},{"issue":"3","key":"10.1016\/j.vaccine.2014.06.025_bib0215","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.coi.2011.03.005","article-title":"Dengue vaccines: progress and challenges","volume":"23","author":"Coller","year":"2011","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2014.06.025_bib0220","doi-asserted-by":"crossref","first-page":"e64024","DOI":"10.1371\/journal.pone.0064024","article-title":"Human IgG subclasses against enterovirus Type 71: neutralization versus antibody dependent enhancement of infection","volume":"8","author":"Cao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2014.06.025_bib0225","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1743-422X-8-106","article-title":"Antibody dependent enhancement infection of enterovirus 71 in vitro and in vivo","volume":"8","author":"Han","year":"2011","journal-title":"Virol J"},{"issue":"4","key":"10.1016\/j.vaccine.2014.06.025_bib0230","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00430-013-0289-y","article-title":"Subneutralizing antibodies to enterovirus 71 induce antibody-dependent enhancement of infection in newborn mice","volume":"202","author":"Chen","year":"2013","journal-title":"Med Microbiol Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2014.06.025_bib0235","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1128\/CVI.00108-10","article-title":"Enterovirus 71 infection of monocytes with antibody-dependent enhancement","volume":"17","author":"Wang","year":"2010","journal-title":"Clin Vaccine Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14008147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14008147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T09:41:48Z","timestamp":1689327708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14008147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":47,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0264410X14008147"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.06.025","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}